发明授权
US08143241B2 DNA damage repair inhibitors for treatment of cancer 有权
DNA损伤修复抑制剂治疗癌症

DNA damage repair inhibitors for treatment of cancer
摘要:
The present invention relates to the recognition that inhibition of the base excision repair pathway is selectively lethal in cells which are deficient in HR dependent DNA DSB repair. Methods and means relating to the treatment of cancers which are deficient in HR dependent DNA DSB repair using inhibitors which target base excision repair components, such as PARP, is provided herein.
公开/授权文献
信息查询
0/0